- According to the Oral Cancer Foundation, approximately 34,000 people will be affected by oral cancer in the United States this year and roughly 8,000 will die. This translates to one death every hour of every day.
- A 2007 study conducted by researchers at Johns Hopkins University and published by the New England Journal of Medicine concluded that Human Papilloma Virus (HPV) nowadays is strongly associated with oral cancer among people even without traditional risk factors of tobacco and alcohol abuse.
Any dental office with attention to the holistic nature of dental treatment will now offer an important adjunctive screening test, the Vizilite, to catch oral cancer as early as possible.
An annual ViziLite Plus exam, after a conventional visual examination, represents an integral part of comprehensive oral-cancer screenings. The screenings help dentists detect oral cancer in its early stages, as well as precancerous tissue. Detection promotes early intervention and prolongs life expectancy.
In the past, oral cancer predominately struck men, adults over 40, African Americans, smokers and heavy alcohol drinkers. The new cancer-screening procedure “ViziLite® Plus with TBlue630” is simple, quick, non-invasive, pain-free and effective. We found that ‘Humana Dental’ will cover the screening once a year beginning April 1, 2008, and we are sure that other insurance companies will or may have already started to follow.